Humanized GPIbα–von Willebrand factor interaction in the mouse

Autor: Yu-ichi Kamikubo, Rashmi Sood, Yosuke Morodomi, Stefano Forli, Jennifer N. Orje, Robert R. Montgomery, Zaverio M. Ruggeri, Sachiko Kanaji, Sandra L. Haberichter, Alessandro Zarpellon, Yunfeng Chen, Jerome Eberhardt, Taisuke Kanaji, Scot A. Fahs
Rok vydání: 2018
Předmět:
Blood Platelets
0301 basic medicine
Genetically modified mouse
Protein Conformation
animal diseases
Transgene
Mice
Transgenic

Plasma protein binding
Molecular Dynamics Simulation
030204 cardiovascular system & hematology
Platelet membrane glycoprotein
Thrombosis and Hemostasis
Mice
Protein Aggregates
Structure-Activity Relationship
03 medical and health sciences
0302 clinical medicine
Von Willebrand factor
Bleeding time
hemic and lymphatic diseases
von Willebrand Factor
medicine
Animals
Humans
Platelet
Crosses
Genetic

Hemostasis
biology
medicine.diagnostic_test
Chemistry
Thrombosis
Exons
Hematology
Surface Plasmon Resonance
Molecular biology
Molecular Docking Simulation
030104 developmental biology
Platelet Glycoprotein GPIb-IX Complex
cardiovascular system
biology.protein
Protein Multimerization
Biomarkers
circulatory and respiratory physiology
Protein Binding
Zdroj: Blood Advances. 2:2522-2532
ISSN: 2473-9537
2473-9529
DOI: 10.1182/bloodadvances.2018023507
Popis: The interaction of platelet glycoprotein Ibα (GPIbα) with von Willebrand factor (VWF) initiates hemostasis after vascular injury and also contributes to pathological thrombosis. GPIbα binding to the VWF A1 domain (VWFA1) is a target for antithrombotic intervention, but attempts to develop pharmacologic inhibitors have been hindered by the lack of animal models because of the species specificity of the interaction. To address this problem, we generated a knockin mouse with Vwf exon 28–encoding domains A1 and A2 replaced by the human homolog (VWFh28). VWFh28 mice (M1HA) were crossbred with a transgenic mouse strain expressing human GPIbα on platelets (mGPIbαnull;hGPIbαTg; H1MA) to generate a new strain (H1HA) with humanized GPIbα-VWFA1 binding. Plasma VWF levels in the latter 3 strains were similar to those of wild-type mice (M1MA). Compared with the strains that had homospecific GPIbα-VWF pairing (M1MA and H1HA), M1HA mice of those with heterospecific pairing had a markedly greater prolongation of tail bleeding time and attenuation of thrombogenesis after injury to the carotid artery than H1MA mice. Measurements of GPIbα-VWFA1 binding affinity by surface plasmon resonance agreed with the extent of observed functional defects. Ristocetin-induced platelet aggregation was similar in H1HA mouse and human platelet-rich plasma, and it was comparably inhibited by monoclonal antibody NMC-4, which is known to block human GPIbα-VWFA1 binding, which also inhibited FeCl3-induced mouse carotid artery thrombosis. Thus, the H1HA mouse strain is a fully humanized model of platelet GPIbα-VWFA1 binding that provides mechanistic and pharmacologic information relevant to human hemostatic and thrombotic disorders.
Databáze: OpenAIRE